Author: Jillian Rhodes
Jillian is a New York attorney turned marketing strategist, specializing in brand safety, FTC guidelines, and risk mitigation for influencer programs. She consults for brands and agencies looking to future-proof their campaigns. Jillian is all about turning legal red tape into simple checklists and playbooks. She also never misses a morning run in Central Park, and is a proud dog mom to a rescue beagle named Cooper.
How to run a 100-creator annual roster without proportional headcount — tiered briefs, AI quality review, rights architecture, and attribution dashboards explained.
Follower count no longer predicts reach. Here’s a practical framework for rebuilding creator discovery around interest-graph distribution and topic cluster alignment.
CMOs at Cannes Lions debated agentic AI deployment thresholds. Here’s how to define human judgment minimums before autonomous campaign systems go live.
EU investigations into Meta’s addictive design features are forcing brands to rethink algorithm dependency, reach modeling, and compliance documentation for youth-adjacent campaigns.
Learn how to allocate your always-on creator program budget across creator fees, paid amplification, attribution infrastructure, and GEO content optimization in one annual model.
CPC, CTR, and direct conversion are no longer advanced metrics—they’re the minimum baseline every creator relationship must clear to justify spend. Here’s how to enforce them.
Social commerce disclosure on TikTok Shop and Instagram requires brands to rethink caption structure, overlay placement, and FTC language before the checkout tap.
Unilever and TikTok’s pivot from follower reach to interest cluster reach demands that procurement teams overhaul creator selection, rate benchmarks, and KPIs from the ground up.
How to structure participation agreements, revenue-share terms, and FTC disclosure architecture when licensing UGC clipping network access instead of individual creator deals.
Finance wants payback in 90 days. Creators need 12 months to perform. Here’s how to build phased activation sequences that satisfy both without killing long-term results.